Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Dec;103(12):1155-1162.
doi: 10.1136/archdischild-2017-314181. Epub 2018 May 2.

Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis

Ibtihal Siddiq Abdelgadir et al. Arch Dis Child. 2018 Dec.

Abstract

Importance: Children with neurodevelopmental disorders have a higher prevalence of sleep disturbances. Currently there is variation in the use of melatonin; hence, an up-to-date systematic review is indicated to summarise the current available evidence.

Objective: To determine the efficacy and safety of melatonin as therapy for sleep problems in children with neurodevelopmental disorders.

Data sources and study selections: PubMed, Embase, the Cumulative Index to Nursing and Allied Health Literature and the Cochrane Central Register of Controlled Trials were searched from inception up to January 2018. Two reviewers performed data assessment and extraction. We assessed randomised controlled trials that compared melatonin with placebo or other intervention for the management of sleep disorders in children (<18 years) with neurodevelopmental disorders.

Data extraction and synthesis: We identified 3262 citations and included 13 studies in this meta-analysis.

Main outcomes: Main outcomes included total sleep time, sleep onset latency, frequency of nocturnal awakenings and adverse events.

Results: Thirteen randomised controlled trials (n=682) met the inclusion criteria. A meta-analysis of nine studies (n=541) showed that melatonin significantly improved total sleep time compared with placebo (mean difference (MD)=48.26 min, 95% CI 36.78 to 59.73, I2=31%). In 11 studies (n=581), sleep onset latency improved significantly with melatonin use (MD=-28.97, 95% CI -39.78 to -18.17). No difference was noted in the frequency of nocturnal awakenings (MD=-0.49, 95% CI -1.71 to 0.73). No medication-related serious adverse event was reported.

Conclusion: Melatonin appeared safe and effective in improving sleep in the studied children. The overall quality of the evidence is limited due to heterogeneity and inconsistency. Further research is needed.

Keywords: neurodevelopment; paediatric practice; sleep; therapeutics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

MeSH terms

Substances

LinkOut - more resources